Several previous studies have reported a correlation between rhGH treatment response and genotype in Noonan syndrome, with patients carrying the PTPN11 pathogenic variant having a poor response to rhGH treatment [36, 37]. The gene discussed is PTPN11; the disease is Noonan syndrome.